Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.
Carolina Ayelen IsnardiKaren RobertsVerónica SauritIngrid PetkovicRoberto Miguel BáezRosana Maris QuintanaYohana Soledad TisseraSofía OrnellaMaria Eugenia D'Angelo ExeniCecilia Nora PisoniVanessa Viviana Castro CoelloGuillermo BerbottoMaría J Haye SalinasEdson VelozoÁlvaro A Reyes TorresRomina TantenMarcos David ZelayaCarla Andrea GobbiCarla G AlonsoMaría de Los Ángeles SeverinaFlorencia ViveroAlba PaulaAdriana Karina CogoGelsomina AlleMariana PeraRomina Estefania NietoMicaela Ana CosattiCecilia AsnalDora PereiraJuan A AlbieroVerónica G SavioFederico N MaldonadoMaría Julieta GambaNoelia F GermánAndrea BañosJosefina Gallino YanziMaría Soledad Gálvez ElkinJulieta S MorbiducciMaría Victoria MartireHernán Maldonado FiccoMaria Marcela SchmidJaime A Villafañe TorresMaria de Los Ángeles CorreaMaría Alejandra MedinaMaría Alejandra CusaJulia ScafatiSantiago E AgüeroNicolás M Lloves SchenoneEnrique Roberto SorianoCesar GrafBernardo A Pons-EstelGimena GomezMargarita LandiMaría Celina de la VegaGuillermo J Pons-Estelnull nullPublished in: Clinical rheumatology (2022)
This study has been registered in ClinicalTrials.gov under the number NCT04568421. Key Points • High disease activity, and treatment with glucocorticoids and rituximab were associated with poor COVID-19 outcome in patients with rheumatic diseases. • Some socioeconomic factors related to social inequality, including non-Caucasian ethnicity and public health insurance, were associated with hospitalization due to COVID-19.
Keyphrases
- coronavirus disease
- sars cov
- health insurance
- disease activity
- systemic lupus erythematosus
- rheumatoid arthritis
- healthcare
- respiratory syndrome coronavirus
- rheumatoid arthritis patients
- ankylosing spondylitis
- juvenile idiopathic arthritis
- diffuse large b cell lymphoma
- emergency department
- metabolic syndrome
- machine learning
- adipose tissue
- deep learning